15 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
to provide a fixed component of compensation reflecting the executive’s skill set, experience, role and responsibilities.
Effective as of January 1, 2023
S-3
EX-4.4
ALGS
Aligos Therapeutics Inc
4 Nov 21
Shelf registration
4:57pm
, the Trustee shall exercise the rights and powers vested in it by this Indenture and use the same degree of care and skill in their exercise as a prudent
DEF 14A
jbnc o3ya
27 Apr 21
Definitive proxy
4:15pm
424B4
dzgndus9cf
19 Oct 20
Prospectus supplement with pricing info
5:21pm
S-1
m35mm7m
25 Sep 20
IPO registration
5:27pm
S-1
EX-10.1
r42qob8t9liz ukt69t
25 Sep 20
IPO registration
5:27pm
S-1
EX-10.2
tlg0z0pgv94h67f8t
25 Sep 20
IPO registration
5:27pm
DRS
mqj8 98e9i
26 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next